These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 6289039

  • 1. Urinary and plasma vitamin D3 metabolites in the nephrotic syndrome.
    Lambert PW, De Oreo PB, Fu IY, Kaetzel DM, von Ahn K, Hollis BW, Roos BA.
    Metab Bone Dis Relat Res; 1982; 4(1):7-15. PubMed ID: 6289039
    [Abstract] [Full Text] [Related]

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Bone turnover in rats treated with 1,25-dihydroxyvitamin D3, 25-hydroxyvitamin D3 or 24,25-dihydroxyvitamin D3.
    Mortensen BM, Gautvik KM, Gordeladze JO.
    Biosci Rep; 1993 Feb; 13(1):27-39. PubMed ID: 8392394
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Vitamin D metabolism and parathyroid function in man.
    Mawer EB, Backhouse J, Hill LF, Lumb GA, De Silva P, Taylor CM, Stanbury SW.
    Clin Sci Mol Med; 1975 May; 48(5):349-65. PubMed ID: 165031
    [Abstract] [Full Text] [Related]

  • 9. Decreased free 1,25-dihydroxycholecalciferol index in patients with the nephrotic syndrome.
    Auwerx J, De Keyser L, Bouillon R, De Moor P.
    Nephron; 1986 May; 42(3):231-5. PubMed ID: 3753749
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Vitamin D metabolites and calcium metabolism in patients with nephrotic syndrome and normal renal function.
    Goldstein DA, Haldimann B, Sherman D, Norman AW, Massry SG.
    J Clin Endocrinol Metab; 1981 Jan; 52(1):116-21. PubMed ID: 6969729
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Isolation and identification of 1alpha-hydroxy-3-epi-vitamin D3, a potent suppressor of parathyroid hormone secretion.
    Brown AJ, Ritter CS, Weiskopf AS, Vouros P, Sasso GJ, Uskokovic MR, Wang G, Reddy GS.
    J Cell Biochem; 2005 Oct 15; 96(3):569-78. PubMed ID: 16088954
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Dose-response effects of supplementation with calcifediol on serum 25-hydroxyvitamin D status and its metabolites: A randomized controlled trial in older adults.
    Vaes AMM, Tieland M, de Regt MF, Wittwer J, van Loon LJC, de Groot LCPGM.
    Clin Nutr; 2018 Jun 15; 37(3):808-814. PubMed ID: 28433267
    [Abstract] [Full Text] [Related]

  • 18. Vitamin D metabolites do not alter parathyroid hormone secretion acutely.
    Magliola L, Anast CS, Forte LR.
    Bone Miner; 1986 Dec 15; 1(6):495-505. PubMed ID: 3509783
    [Abstract] [Full Text] [Related]

  • 19. Long-term administration of vitamin D3 metabolites alters PTH-responsive osteoblastic adenylate cyclase in rats.
    Mortensen B, Gordeladze JO, Aksnes L, Gautvik KM.
    Calcif Tissue Int; 1990 May 15; 46(5):339-45. PubMed ID: 2159835
    [Abstract] [Full Text] [Related]

  • 20. The role of dietary calcium in the physiology of vitamin D toxicity: excess dietary vitamin D3 blunts parathyroid hormone induction of kidney 1-hydroxylase.
    Beckman MJ, Johnson JA, Goff JP, Reinhardt TA, Beitz DC, Horst RL.
    Arch Biochem Biophys; 1995 Jun 01; 319(2):535-9. PubMed ID: 7786039
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.